person

Joseph Zohar, MD

ORCID 0000-0002-6925-9104
as of 2026-07-01
Monitor thisAsk about this
at a glance
Roles: Principal Investigator, Author
KOL signal score 8
4 publications · 0 high-value
Cross-drug reach: 4 competitor drugs
Synthesized from structured facts only — each point cited above.

Profile

Affiliation
Tel Aviv University
Roles
Principal Investigator, Author
KOL signal
8
Publications
4 (0 high-value)
Trial investigator
no

Publishes on

4 drugs
Brexpiprazole (Rexulti)Cariprazine (Vraylar)AmisulprideXanomeline-trospium (Cobenfy)

Trials led

2
Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)
NCT00229385—Completed
Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype?
NCT00269464—Completed

Publications & congress

2
Dose-dependent pharmacological mechanisms within the Neuroscience-based Nomenclature: a new concept to facilitate neuroscience-based prescribing.
The lancet. Psychiatry · 2026
Global Perspectives on CNS Drug Innovation: Achievements, Barriers, and Priorities for the Next Decade.
The international journal of neuropsychopharmacology · 2026

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
Brexpiprazole (Rexulti)
drug
Cariprazine (Vraylar)
drug
Amisulpride
drug
Xanomeline-trospium (Cobenfy)
drug
PRINCIPAL_INVESTIGATOR
Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)
trial
Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype?
trial